A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in adult subjects with rheumatoid arthritis receiving Study Drug or placebo.
PRA Delivers Study Start-up Success
PRA was awarded a rheumatoid arthritis study contract based on our strategy for achieving first-patient-in (FPI) by the end of the calendar year.…
Ask the Experts Roundtable: Insights on Pfizer and Moderna’s Recent mRNA-Based Vaccine Developments
As the COVID-19 pandemic continues to challenge humankind worldwide, the medical industry and professionals alike are developing vaccines at…
Targeting Patients In A Complex Phase II Rheumatoid Arthritis Study
Targeting Patients In A Complex Phase IIa Rheumatoid Arthritis Study.